Status | Study |
Terminated |
Study Name: A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy Condition: Epithelial Ovarian Cancer Date: 2013-03-18 Interventions: Drug: CAELYX CAELYX 50 mg per |
Not yet recruiting |
Study Name: Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer Condition: Epithelial Ovarian Cancer Date: 2012-09-04 |
Completed |
Study Name: FES-PET to Determine ER-expression in Epithelial Ovarian Cancer Condition: Epithelial Ovarian Cancer Date: 2011-09-20 Interventions: Other: FES-PET Patients undergo FES-PET prior to obtaining histology |
Completed |
Study Name: Safety of Active Immunotherapy in Subjects With Ovarian Cancer Condition: Ovarian Epithelial Cancer Date: 2011-09-14 Interventions: Biological: Procure The IMP (I |
Terminated |
Study Name: Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy Condition: Ovarian Carcinoma Date: 2010-08-01 Interventions: Drug: Cytophosphan, Celecoxib, Methotrexate Metronomic Che |
Withdrawn |
Study Name: Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity Condition: Recurrent Ovarian Carcinoma Date: 2009-07-17 Interventions: Drug: Cisplatin PLATINOL® |
Terminated |
Study Name: Intraperitoneal (IP) Cisplatin Given With Paclitaxel to Treat Epithelial Ovarian Cancer Condition: Epithelial Ovarian Cancer Date: 2009-04-27 Interventions: Drug: Intraperitoneal (IP) Cisplatin For patients who have had neoadjuvant chemotherapy followed by opti |
Completed |
Study Name: Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type Condition: Epithelial Ovarian Cancer Date: 2009-03-12 Interventions: Drug: Pegylated liposomal doxorubicin |
Completed |
Study Name: Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma Condition: Ovarian Carcinoma Date: 2008-07-23 Interventions: Dietary Supplement: Double-Brewed Green Tea liquid, 4 celsius; 500 mL ID, 3 hours after meals and 1 hour |
Active, not recruiting |
Study Name: Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study Condition: Ovarian Carcinoma Date: 2008-07-14 Interventions: Other: timing of surgery Surge |